J&J Champions High-SPF Sunscreen Study To Contest FDA-Proposed Cap
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson adds to its argument against FDA's proposed maximum for sun protection factors on sunscreen products with a study refuting concerns about the accuracy of high SPF formula tests.
You may also be interested in...
FDA Considers Capping SPF Values At 50+ Despite Efficacy Data
FDA might cap sun protection values at 50 or 50+ so as not to mislead consumers about the clinical benefit of sunscreens with higher SPF values, according to a proposed rule.
FDA Considers Capping SPF Values At 50+ Despite Efficacy Data
FDA might cap sun protection values at 50 or 50+ so as not to mislead consumers about the clinical benefit of sunscreens with higher SPF values, according to a proposed rule.
FDA Considers Capping SPF Values At 50+ Despite Efficacy Data
FDA might cap sun protection values at 50 or 50+ so as not to mislead consumers about the clinical benefit of sunscreens with higher SPF values, according to a proposed rule.